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Abstract 
Heat shock protein 72 (HSP72) and glycoprotein 96 (gp96) are highly expressed in cancer tissues. Recent studies 
indicate the possible roles of HSP72 and gp96 in the development and progression of gastrointestinal carcinomas but 
detailed information is still ambiguous. The aim of the study is to investigate the correlation between 
clinicopathology and expression of HSP72 and gp96 in human esophageal squamous cell carcinoma. The expression 
of HSP72 and gp96 was studied in 120 human esophageal squamous cell carcinomas with or without metastasis as 
well as in mucous membrane adjacent to cancers by way of immunohistochemistry. HSP72 immunoreactivities were 
detected in 112 of 120 primary tumors (93.3%) and in 30 of 120 mucous membranes adjacent to cancers (25.0%). 
Gp96 detected in esophageal squamous cell carcinoma and in mucous membrane adjacent to cancer was 85.0% and 
20.0% respectively. Both HSP72 and gp96 mainly stained in cytoplasm. HSP72 and gp96 expression in esophageal 
squamous cell carcinomas with metastasis was significantly higher than those with non-metastasis (P < 0.05). The 
results indicate that there exists a significant correlation between the expression of HSP72 and gp96 and the 
progression of esophageal squamous cell carcinomas. HSP72 and gp96 expression were significantly associated with 
the presence of tumor infiltration, lymph node and remote metastasis. The high-level expression of HSP72 and gp96 
may be used as diagnostic or prognostic markers for esophageal squamous cell carcinoma.   
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1.Introduction 
The Heat shock protein (HSP) family is a highly conserved group of cellular proteins and is up-
regulated under stress conditions, such as heat, hypoxia, serum deprivation, neoplasia and virus infection 
[1-3]. It functions as molecular chaperone and biochemical regulator to mediate cell growth, apoptosis, 
protein homeostasis and cellular targets of peptides [2]. Aside from their response to heat shock and 
chemical or physical stress stimuli, HSPs have been reported to be overexpressed in a wide range of 
human tumors including breast, endometrial, ovarian, colon, lung and prostate [4]. Studies have also 
shown that HSP expression have a close relationship with carcinoma prognosis [4,5]. They may combine 
with oncogene products to form complexes and transport them into intracellular special sites and promote 
cancer cell proliferation and heterogeneous differentiation [6,7]. Recent studies have also shown that 
HSP72 and gp96 are highly expressed in cancer tissues and have been used as prognostic markers in some 
tumors [8-10]. 
Study indicates the possible roles of HSP72 and gp96 in the development and progression of 
gastrointestinal carcinomas but detailed information is still ambiguous [11]. Esophageal squamous cell 
carcinoma is one of the most malignant cancers, until now there are few sensitive biomarkers in the 
diagnosis and prognosis of esophageal squamous cell carcinoma. There may be a correlation between the 
progression of esophageal squamous cell carcinoma and over-expression of HSP72 and gp96, but now 
there are few reports about expression of HSP72 and gp96 in esophageal squamous cell carcinoma. The 
present study aimed to estimate the extent of the immunohistochemical expression of HSP72 and gp96 
proteins in tumoral specimens obtained from esophageal cancer patients. We also aimed to evaluate the 
association between the extent of expression of HSP staining and various clinicopathological parameters, 
tumor proliferative capacity. The results showed that there exists a significant correlation between the 
expression of HSP72 and gp96 and the progression in esophageal squamous cell carcinoma. 
2.Materials and Methods 
2.1.Immunochemistry reagents 
Mouse anti-human HSP72 monoclonal antibody was obtained from StressGen Biotechnologies 
(Victoria, British Columbia, Canada) and mouse anti-human gp96 monoclonal antibody was purchased 
from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). EnVisionTM kits were purchased from Dako 
Corp (Carpinteria, CA, USA). 
2.2.Tissue samples  
This investigation was approved by the Ethics Committee on Human Study at Shaanxi University of 
Chinese Medicine (2004-4B).Paraffin specimens of primary esophageal squamous cell carcinoma from 
120 patients undergoing esophageal resection were collected from the affiliated Hospital, Shaanxi 
University of Chinese Medicine, Xianyang, China from 2003 to 2008. None of the patients received any 
kind of anti-cancer treatment or other therapies prior to surgery. The patients consisted of 93 males and 27 
females, with a mean age of 57.5± 6.6 years, ranging from 35 to 78 years. Routine pathological diagnosis 
showed that all cases were squamous cell carcinoma. Tumors were categorized as: infiltrative type in 36 
(30%), massive type in 36 (26.7%), ulcerative type in 28 (23.3%) and constricting type in 24 (20%) out of 
120 cases. Sixty-seven cases were well-differentiated type (grade I) and 29 cases were moderately-
differentiated type (grade II), while 24 cases were poorly differentiated (grade III). Among the cases, 98 
cases had regional lymph node metastases, and 56 cases had remote metastases. Tumors staging was 
296  Xiaoping Wang et al. / Procedia Environmental Sciences 8 (2011) 294 – 300
assessed using the 5th edition of the Tumor, Node, Metastasis (TNM) system according to the Union 
Internationale Contra la Cancrum (UICC) and the American Joint Committee on Cancer (AJCC); they 
were classified as T1 (n = 20, 16.7%), T2 (n = 22, 18.3%), T3 (n = 40, 33.3%) and T4 (n =38, 31.7%). 
Twenty-two (18.3%) patients were node negative (N0), and 98 (81.7%) node positive (N1, n =45, 37.5% 
and N2, n = 53, 44.2%). Organ metastasis was noted in 56 (46.7%) out of 120 patients examined. The 
specimens were fixed in 10% buffered formalin and embedded in paraffin. Serial sections, 5-μm-thick, 
were cut and placed on silane-coated glass slides. 
2.3.Staining methods 
All sections were deparaffinized and rehydrated with graded alcohols. Endogenous peroxidase was then 
blocked with 3 mL/L H2O2 diluted in methanol for 30 min at room temperature. Antigen retrieval was 
performed by treating the slides in citrate buffer in a microwave for 10 min. The slides were incubated in a 
moist chamber with HSP72 mouse monoclonal antibody (1:100) and gp96 mouse monoclonal antibody 
(1:100) at 4͠ overnight. After a complete wash in phosphate buffered saline (PBS), the slides were 
incubated with horseradish peroxidase labeled goat anti-mouse antibody (1:100) for 45 min at 37͠. After 
a complete wash in PBS, the slides were developed in 0.5g/L freshly prepared 3,3’-diaminobenzedine 
solution (DAB, Sigma Co, St.Louis, Mo, USA) for 8 min, and then counterstained with hematoxylin, 
dehydrated, air dried, and mounted. Normal mouse IgG was used to substitute for the primary antibody as a 
negative control. No specific immunoreactivity was detected in these tissue sections. Two of the authors 
initially determined the fields simultaneously using a double-headed light microscope. The evaluation of 
HSP72 and gp96 positive cells was performed on high-power fields (× 400) using a standard light 
microscope. Only distinctive intranuclear or intra-cytoplasm immunoreactivity was considered positive. In 
each case, more than 1000 cells were counted and the percentage of immunoreactivity was independently 
determined. When interobserver differences were greater than 5%, the immunostained slides were re-
examined simultaneously using a using a double-headed light microscope and the percentage of positive 
cells were determined. When interobserver differences were less than 5%, the mean value was obtained as 
the positive rate.  
2.4.Statistical analysis  
HSP72 and gp96 expression differences between esophageal squamous cell carcinomas and mucous 
membrane adjacent to cancer were analyzed statistically using u test. The relationship between expression 
of HSP72 and gp96 in esophageal squamous cell carcinoma tissue with or without metastasis was 
analyzed statistically usingȤ2 test. P < 0.05 was considered statistically significant.  
3.Results 
3.1.Expression of HSP72 and gp96 in esophageal squamous cell carcinomas and mucous membrane 
adjacent to cancer  
HSP72 immunoreactivities were detected in 112 of 120 primary tumors (93.3%) and in 30 of 120 
mucous membranes adjacent to cancers (25.0%). Gp96 detected in esophageal squamous cell carcinoma 
and in mucous membrane adjacent to cancer was 85.0% and 20.0% respectively. HSP72 and gp96 
proteins were mainly presenting a cytoplasmic and occasionally membraneous pattern of staining. 
Representative immunostainings for HSP72 and gp96 are illustrated in Figure 1. HSP72 and gp96 
positive rates in esophageal squamous cell carcinoma groups were significantly higher than that in 
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mucous membrane adjacent to cancer (P < 0.01).  
3.2.Relationship between clinicopathology and expression of HSP72, gp96 in esophageal squamous cell 
carcinomas   
Results showed that HSP72 and gp96 expressed higher in low differentiation of esophageal squamous 
cell carcinomas than that in tissues adjacent to cancers (P < 0.01). HSP72 and gp96 positive rates in 
lymph node metastasis and remote metastasis groups were 100%. There were significant differences of 
HSP72 and gp96 expression between metastasis groups and non-metastasis groups (P < 0.05). To assess 
if HSPs bear a pronounced prognostic effect in patient subgroups, we conducted an extensive Kaplan-
Meier analysis of HSP72 and gp96 protein expressions (low vs high). We stratified by pT stage (small vs 
large tumor size, pT1/T2 vs pT3/T4), tumor grading (poorly vs moderately and well differentiated), nodal 
status (absence vs presence of lymph node metastases, pN0 vs pN1/N2), presence of organ metastases 
(pM0 vs pM1). In cross-tables, HSP72 and gp96 expression were significantly associated with tumor size, 
the presence of organ metastases and lymph node positivity (Table 1). These results suggest that there 
exists a significant correlation between expression of both HSP72 and gp96 and progression of 
esophageal squamous cell carcinomas.  
 
 
 
 
 
Fig. 1. Immunohistochemistry for HSP72 and gp96 in esophageal squamous cell carcinoma cells (counterstained with hematoxylin), 
× 400. Distinctive intra-cytoplasm immunoreactivity was detected for HSP72 (A), and gp96 (B) in esophageal squamous cell cancer 
cells. 
Table 1 Relationship between clinicopathology and immunoreactivity of hsp72 and gp96 in esophageal squamous cell carcinomas 
Pathologic types n HSP72 gp96
- (%) + (%) - (%) + (%) 
Tissues adjacent to cancer 120 90 (75.0) 30 (25.0) 96 (80.0) 24 (20.0) 
Esophageal carcinomasa 120 8 (6.7) 112 (93.3) 18 (15.0) 102 (85.0) 
Well differentiatedb 67 6 (9.0) 61 (91.0) 11 (16.4) 56 (83.6) 
Moderately differentiatedb 29 2 (6.9) 27 (93.1) 4 (13.8) 25 (86.2) 
Poorly differentiatedb 24 0 (0) 24 (100) 3 (12.5) 21 (87.5) 
Lymph node metastasisc 98 0 (0) 98 (100) 0 (0) 98 (100) 
Lymph node non-metastasis 22 8(36.4) 14 (63.6) 18 (81.8) 4 (18.2) 
Remote metastasisd 56 0 (0) 56 (100) 0 (0) 56 (100) 
Remote non-metastasis 64 8 (12.5) 56 (87.5) 18 (28.1) 46 (71.9) 
pT1 20 4(20) 16(80) 6(30) 14(70) 
pT2 22 2(9.1) 20(90.9) 3(13.6) 17(77.3) 
pT3 40 2(5) 38(95) 5(12.5) 35(87.5) 
A  B  
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pT4 38 2(5.26) 38(100) 2(5.3) 36(94.7) 
pN0 22 8(36.4) 14(63.6) 18(81.8) 4(18.2) 
pN1 45 0(0) 45(100) 0(0) 45(100) 
pN2 53 0(0) 53(100) 0(0) 53(100) 
pM0 64 8(12.5) 56(87.5) 18(28.1) 46(71.9) 
pM1 56 0(0) 56(100) 0(0) 56(100) 
Tumors staging was assessed using the 5th edition of the Tumor, Node, Metastasis (TNM) system and stratified by pT stage (small vs 
large tumor size, pT1/T2 vs pT3/T4), tumor grading (poorly vs moderately and well differentiated), nodal status (absence vs 
presence of lymph node metastases, pN0 vs pN1/N2), presence of organ metastases (pM0 vs pM1). aP < 0.01, bP < 0.01, vs tissues 
adjacent to cancers; cP < 0.05, dP < 0.05, vs non-metastasis groups; P < 0.05, pT1,T2 vs pT3,T4; P < 0.05, pN1,N2 vs pN0; P < 0.05, 
pM1 vs pM0. 
4.Discussion 
In this study we examined the expressions of HSP72 and gp96 in 120 esophageal squamous cell 
carcinoma samples by immunohistochemistry. The results showed that almost all of the detected 
esophageal squamous cell carcinomas expressed HSP72, and majority of tumors expressed gp96, which 
had significant differences compared with that in mucous membrane adjacent to cancers. By way of 
immunohistochemistry, we found that there was a definite correlation between expression of both HSP72 
and gp96 and development of esophageal squamous cell carcinomas.  
The Heat shock protein (HSP) family is group of highly conserved proteins synthesized after heat 
induction or other stressors [1-3]. In mammalian cells, this system is divided into two predominant 
categories, which appear to be structurally and functionally related: the heat shock proteins (HSPs) and 
the glucose-regulated proteins (grps) [1]. During the growth and development of normal cells, HSP70 is 
constitutively expressed at low levels but the expression was dramatically enhanced by stressful 
conditions [2]. Heat shock protein 72, belonging to the family of HSP70, is a highly conserved protein 
synthesized under various stresses. In non-transformed cells at normal conditions, Hsp72 is expressed at 
very low levels. It is, however, present at elevated levels in the major fraction of tumors and in many 
transformed cell lines [12,13]. It is commonly assumed that in tumor cells the expression of HSP72 at 
elevated levels is the consequence of oncogenic transformation and enhanced expression of HSP72 has a 
close relationship with epithelial carcinoma cells growth [13]. Up-regulated expression of the HSP70 
family in tumor cells may be a requirement to serve as molecular chaperones in regulating and stabilizing 
oncofetal protein and mutant oncogene products during tumor growth process [14]. In normal cells, gp96 
expression could also be induced by various stresses to function as molecular chaperones [1-3]. Some 
researchers have implied that enhanced expression of gp96 has a close relationship with cancer cells 
growth [15,16]. High level expression of gp96 could contribute to tumorigenicity of certain tumors [16]. 
Recent studies have shown that HSP72 and gp96 are highly expressed in cancer tissues and have been 
used as prognostic markers in some tumors [8-10]. However, few reports have studied the expression of 
gp96 in esophageal squamous cell carcinomas, especially during the course of tumor growth and 
differentiation, in simultaneous comparison with HSP72. In this experiment, we found that HSP72 and 
gp96 were highly expressed when esophageal squamous cell carcinomas progressed, but their roles in 
esophageal squamous cell carcinoma are not clear.  
It is reasonable to propose that HSP72 and gp96 up-regulation in these tumor cells are closely related 
with tumor cell survival and proliferation. Studies revealed that considerable expression of HSPs was 
found in tumor cells, showing that HSPs may be induced by other stresses and participate in broader array 
of defenses during cell growth and cell differentiation of tumors [5-7]. Thus, it may be presumed that 
under various stimuli and stressful conditions, in order to avoid the damage caused by deleterious factors 
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such as nicrosamines-oncogenesis evocator, esophageal squamous cell has to transcribe and translate high 
levels of HSPs in order to sustain normal metabolism and functions of cells. Under these conditions, 
esophageal squamous cell should synthesize HSPs rapidly to exert a protective role for esophageal 
squamous cells. The progression of esophageal squamous cell carcinoma is a gradual process under the 
long-term influence of various stimuli. During the process, inducible HSP synthesis increases gradually. 
This viewpoint was confirmed by our results, in that HSP72 and gp96 were expressed at a higher level in 
esophageal squamous cell carcinoma than that in esophageal tissues adjacent to cancer. Recent researches 
have suggested that HSPs take part in cell growth and proliferation in several ways such as signal 
transduction and cell cycle regulation through combining certain proto-oncogene products. This indicates 
that these proliferating cells need higher level of HSPs to maintain the stability of tumor proteome [17]. It 
is believed that tumor cells are a group of highly proliferative heterogeneous cells which progress 
gradually through mutant oncogene products [13,16]. Continuous expression of HSP in tumor cells may 
be required to serve as molecular chaperones in regulating and stabilizing these products during tumor 
growth process. At the same time, the existence of mutant or oncogene products may stimulate HSP 
synthesis [6,7].  
The present study further supports the clinical significance of HSP72 and gp96 protein expression in 
the progression of esophageal squamous cell carcinoma. In the study, HSP72 and gp96 expression were 
found to be associated with important clinicopathological characteristics for patients' management. 
Consistently, HSP72 and gp96 expression were significantly associated with the presence of tumor size, 
lymph node and organ metastasis. In our previous studies, we have found over-expression of the HSP70 
or gp96 in human gastrointestinal carcinomas, which have some relationship with progression, invasion 
and metastasis of the cancers [11,12]. Other researcher’s study [18] also showed that overexpression of 
HSP70 was related to tumor configuration, lymph node metastasis, and lymphatic vessel invasion in 
human esophageal squamous cell carcinoma. The studies found histopathological differentiation was 
significantly correlated with the expression of HSP70, while there found no significant association 
between HSP70 expression and patient survival. Our results showed that not only the expression of both 
HSP72 and gp96 in esophageal squamous cell carcinoma was higher than that in tissues adjacent to 
cancer, but also the expression of both HSP72 and gp96 in esophageal squamous cell carcinomas with 
metastasis was definitely higher than that of esophageal squamous cell carcinomas without metastasis. 
The expression of both HSP72 and gp96 in esophageal squamous cell carcinoma was related to the 
differentiated tissue type of esophageal squamous cell cancer. It is presumed that the combined 
measurement of HSP72 and gp96 in esophageal squamous cell carcinoma might be more sensitive than 
that of HSP70 family alone. The results indicate that up-regulation of HSP72 and gp96 is likely to have 
some relationship with progression, invasion and metastasis of esophageal squamous cell carcinomas. 
The expression levels of HSP72 and gp96 may prove useful as diagnostic or prognostic markers for 
esophageal squamous cell carcinoma. 
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